COVID-19 Response: Unprecedented Opportunities In Digital Health & Biotech
Join us on May 19th where experts in the field of medicine, biotech, and investing will focus on two areas of unprecedented opportunity given the current pandemic: The desperate need and requirement for digital health as well as fast-tracking drug commercialization.
Topics include:
Digital health solutions for business and personal medical status certification
New business lines including potential digital immunity passports
Ethical and technical landscape of Identity, Privacy, Track and trace
Advancing investment in AI-directed drug therapies
The expansion of Emergency Use Approvals
Unprecedented time and cost to market modifications driving investment